secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibrx Biosciences, Inc. (INBX)
CIK:        0002007919
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0002007919-24-000016
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inhibrx posts updated corporate presentation; no material details in filing excerpt
--------------------------------------------------------------------------------

- Company posted updated corporate presentation on its website on June 17, 2024.
- No specific pipeline, financial, or milestone updates are visible from the filed excerpt.
- Presentation attached as Exhibit 99.1; full content not included in this 8-K text.
- Routine update without quantitative or event-driven disclosures for investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2007919/000200791924000016/0002007919-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2007919/000200791924000016/inhibrx-20240617.htm
  HTML page:      https://secwatch.observer/filing/0002007919-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer